Exact Mass: 565.2920522000001
Exact Mass Matches: 565.2920522000001
Found 223 metabolites which its exact mass value is equals to given mass value 565.2920522000001
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Cinaciguat
2-[[(2S)-1-[(2S)-2-[[(2S)-1-[(2S)-2-Amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidin-2-yl]methylamino]-3-phenylpropanoyl]pyrrolidine-2-carbonyl]amino]acetic acid
N-Formyl-met-leu-phe-lys
C27H43N5O6S (565.2933898000001)
Phe-Phe-Pro-Arg
Tyr Ile Arg Asp
Val Tyr Arg Glu
Asp Ile Arg Tyr
Asp Ile Tyr Arg
Asp Leu Arg Tyr
Asp Leu Tyr Arg
Asp Arg Ile Tyr
Asp Arg Leu Tyr
Asp Arg Tyr Ile
Asp Arg Tyr Leu
Asp Tyr Ile Arg
Asp Tyr Leu Arg
Asp Tyr Arg Ile
Asp Tyr Arg Leu
Glu Arg Val Tyr
Glu Arg Tyr Val
Glu Val Arg Tyr
Glu Val Tyr Arg
Glu Tyr Arg Val
Glu Tyr Val Arg
Phe Phe Pro Arg
Phe Phe Arg Pro
Phe Ile Thr Trp
Phe Ile Trp Thr
Phe Leu Thr Trp
Phe Leu Trp Thr
Phe Pro Phe Arg
Phe Pro Arg Phe
Phe Arg Phe Pro
Phe Arg Pro Phe
Phe Thr Ile Trp
Phe Thr Leu Trp
Phe Thr Trp Ile
Phe Thr Trp Leu
Phe Trp Ile Thr
Phe Trp Leu Thr
Phe Trp Thr Ile
Phe Trp Thr Leu
Ile Asp Arg Tyr
Ile Asp Tyr Arg
Ile Phe Thr Trp
Ile Phe Trp Thr
Ile Arg Asp Tyr
Ile Arg Tyr Asp
Ile Thr Phe Trp
Ile Thr Trp Phe
Ile Trp Phe Thr
Ile Trp Thr Phe
Ile Tyr Asp Arg
Ile Tyr Arg Asp
Lys Gln Gln Tyr
Lys Gln Tyr Gln
Lys Tyr Gln Gln
Leu Asp Arg Tyr
Leu Asp Tyr Arg
Leu Phe Thr Trp
Leu Phe Trp Thr
Leu Arg Asp Tyr
Leu Arg Tyr Asp
Leu Thr Phe Trp
Leu Thr Trp Phe
Leu Trp Phe Thr
Leu Trp Thr Phe
Leu Tyr Asp Arg
Leu Tyr Arg Asp
Pro Phe Phe Arg
Pro Phe Arg Phe
Pro Arg Phe Phe
Gln Lys Gln Tyr
Gln Lys Tyr Gln
Gln Gln Lys Tyr
Gln Gln Tyr Lys
Gln Tyr Lys Gln
Gln Tyr Gln Lys
Arg Asp Ile Tyr
Arg Asp Leu Tyr
Arg Asp Tyr Ile
Arg Asp Tyr Leu
Arg Glu Val Tyr
Arg Glu Tyr Val
Arg Phe Phe Pro
Arg Phe Pro Phe
Arg Ile Asp Tyr
Arg Ile Tyr Asp
Arg Leu Asp Tyr
Arg Leu Tyr Asp
Arg Pro Phe Phe
Arg Val Glu Tyr
Arg Val Tyr Glu
Arg Tyr Asp Ile
Arg Tyr Asp Leu
Arg Tyr Glu Val
Arg Tyr Ile Asp
Arg Tyr Leu Asp
Arg Tyr Val Glu
Thr Phe Ile Trp
Thr Phe Leu Trp
Thr Phe Trp Ile
Thr Phe Trp Leu
Thr Ile Phe Trp
Thr Ile Trp Phe
Thr Leu Phe Trp
Thr Leu Trp Phe
Thr Trp Phe Ile
Thr Trp Phe Leu
Thr Trp Ile Phe
Thr Trp Leu Phe
Val Glu Arg Tyr
Val Glu Tyr Arg
Val Arg Glu Tyr
Val Arg Tyr Glu
Val Val Trp Tyr
Val Val Tyr Trp
Val Trp Val Tyr
Val Trp Tyr Val
Val Tyr Glu Arg
Val Tyr Val Trp
Val Tyr Trp Val
Trp Phe Ile Thr
Trp Phe Leu Thr
Trp Phe Thr Ile
Trp Phe Thr Leu
Trp Ile Phe Thr
Trp Ile Thr Phe
Trp Leu Phe Thr
Trp Leu Thr Phe
Trp Thr Phe Ile
Trp Thr Phe Leu
Trp Thr Ile Phe
Trp Thr Leu Phe
Trp Val Val Tyr
Trp Val Tyr Val
Trp Tyr Val Val
Tyr Asp Ile Arg
Tyr Asp Leu Arg
Tyr Asp Arg Ile
Tyr Asp Arg Leu
Tyr Glu Arg Val
Tyr Glu Val Arg
Tyr Ile Asp Arg
Tyr Lys Gln Gln
Tyr Leu Asp Arg
Tyr Leu Arg Asp
Tyr Gln Lys Gln
Tyr Gln Gln Lys
Tyr Arg Asp Ile
Tyr Arg Asp Leu
Tyr Arg Glu Val
Tyr Arg Ile Asp
Tyr Arg Leu Asp
Tyr Arg Val Glu
Tyr Val Glu Arg
Tyr Val Arg Glu
Tyr Val Val Trp
Tyr Val Trp Val
Tyr Trp Val Val
Fibrinogen-Binding Peptide
Fibrinogen-Binding Peptide (designed by anticomplementarity hypothesis) is a presumptive peptide mimic of the vitronectin binding site on the fibrinogen receptor. Fibrinogen-Binding Peptide binds fibrinogen and inhibits both the adhesion of platelets to fibrinogen and platelet aggregation, and also inhibits the adhesion of platelets to vitronectin[1].
For-Met-Leu-Phe-Lys-OH
C27H43N5O6S (565.2933898000001)
N-Formyl-Met-Leu-Phe-Lys (fMLFK) is a peptide, acts as a potent and selective agonist of FPR1, with EC50s of 3.5 nM, 6.7 μM and 0.88 μM for FPR1, FPR2 and FPR2-D2817.32G, respectively[1].
2-[[(2S)-1-[(2S)-2-[[(2S)-1-[(2S)-2-Amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidin-2-yl]methylamino]-3-phenylpropanoyl]pyrrolidine-2-carbonyl]amino]acetic acid
N-[(3S,9R,10R)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-1-methyl-4-imidazolesulfonamide
C27H43N5O6S (565.2933898000001)
N-[(3R,9S,10R)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-1-methyl-4-imidazolesulfonamide
C27H43N5O6S (565.2933898000001)
N-[(3S,9R,10S)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-1-methyl-4-imidazolesulfonamide
C27H43N5O6S (565.2933898000001)
N-[(3S,9R,10S)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-1-methyl-4-imidazolesulfonamide
C27H43N5O6S (565.2933898000001)
N-[(3R,9S,10S)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-1-methyl-4-imidazolesulfonamide
C27H43N5O6S (565.2933898000001)
N-[(3R,9R,10R)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-1-methyl-4-imidazolesulfonamide
C27H43N5O6S (565.2933898000001)
N-[(3R,9R,10R)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-1-methyl-4-imidazolesulfonamide
C27H43N5O6S (565.2933898000001)
N-[(3R,9S,10R)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-1-methyl-4-imidazolesulfonamide
C27H43N5O6S (565.2933898000001)
1-(3,5-dimethyl-4-isoxazolyl)-3-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]urea
N-[(3S,9S,10R)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-1-methyl-4-imidazolesulfonamide
C27H43N5O6S (565.2933898000001)
1-(3,5-dimethyl-4-isoxazolyl)-3-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]urea
1-(3,5-dimethyl-4-isoxazolyl)-3-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]urea
N-[(3R,9R,10S)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-1-methyl-4-imidazolesulfonamide
C27H43N5O6S (565.2933898000001)
1-(3,5-dimethyl-4-isoxazolyl)-3-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]urea
N-[(3R,9R,10S)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-1-methyl-4-imidazolesulfonamide
C27H43N5O6S (565.2933898000001)
N-[(3S,9R,10R)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-1-methyl-4-imidazolesulfonamide
C27H43N5O6S (565.2933898000001)
1-(3,5-dimethyl-4-isoxazolyl)-3-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]urea
N-[(3S,9S,10S)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-1-methyl-4-imidazolesulfonamide
C27H43N5O6S (565.2933898000001)
N-[(3S,9S,10S)-9-[(dimethylamino)methyl]-12-[(2R)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-1-methyl-4-imidazolesulfonamide
C27H43N5O6S (565.2933898000001)
N-[(3S,9S,10R)-9-[(dimethylamino)methyl]-12-[(2S)-1-hydroxypropan-2-yl]-3,10-dimethyl-13-oxo-2,8-dioxa-12-azabicyclo[12.4.0]octadeca-1(14),15,17-trien-16-yl]-1-methyl-4-imidazolesulfonamide
C27H43N5O6S (565.2933898000001)
2-amino-3-[hydroxy-[2-[(Z)-pentadec-9-enoyl]oxy-3-pentanoyloxypropoxy]phosphoryl]oxypropanoic acid
C26H48NO10P (565.3015677999999)
2-amino-3-[[3-heptanoyloxy-2-[(Z)-tridec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
C26H48NO10P (565.3015677999999)
2-amino-3-[[3-butanoyloxy-2-[(Z)-hexadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
C26H48NO10P (565.3015677999999)
2-amino-3-[[3-hexanoyloxy-2-[(Z)-tetradec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
C26H48NO10P (565.3015677999999)
2-amino-3-[[2-[(Z)-heptadec-9-enoyl]oxy-3-propanoyloxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
C26H48NO10P (565.3015677999999)
3-[[3-acetyloxy-2-[(Z)-octadec-9-enoyl]oxypropoxy]-hydroxyphosphoryl]oxy-2-aminopropanoic acid
C26H48NO10P (565.3015677999999)
JNJ-31020028
JNJ-31020028 is a selective and brain penetrant antagonist of neuropeptide Y Y2 receptor with pIC50 values of 8.07 and 8.22 for human and rat Y2 receptor, respectively. JNJ-31020028 can be used for the research of nervous disease[1].